Skip to main content
NCBI home page
British Medical Journal (Clinical Research Ed.) logoLink to British Medical Journal (Clinical Research Ed.)
. 1983 Aug 6;287(6389):379–380. doi: 10.1136/bmj.287.6389.379

Adjuvant chemotherapy for early breast cancer.

I E Smith
PMCID: PMC1548920  PMID: 6409315

Full text

PDF
379

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bonadonna G., Brusamolino E., Valagussa P., Rossi A., Brugnatelli L., Brambilla C., De Lena M., Tancini G., Bajetta E., Musumeci R. Combination chemotherapy as an adjuvant treatment in operable breast cancer. N Engl J Med. 1976 Feb 19;294(8):405–410. doi: 10.1056/NEJM197602192940801. [DOI] [PubMed] [Google Scholar]
  2. Brinkley D., Haybrittle J. L. The curability of breast cancer. Lancet. 1975 Jul 19;2(7925):95–97. doi: 10.1016/s0140-6736(75)90003-3. [DOI] [PubMed] [Google Scholar]
  3. Chlebowski R. T., Weiner J. M., Luce J., Hestorff R., Lang J. E., Reynolds R., Godfrey T., Ryden V. M., Bateman J. R. Significance of relapse after adjuvant treatment with combination chemotherapy or 5-fluorouracil alone in high-risk breast cancer. A Western Cancer Study Group Project. Cancer Res. 1981 Nov;41(11 Pt 1):4399–4403. [PubMed] [Google Scholar]
  4. Cooper R. G., Holland J. F., Glidewell O. Adjuvant chemotherapy of breast cancer. Cancer. 1979 Sep;44(3):793–798. doi: 10.1002/1097-0142(197909)44:3<793::aid-cncr2820440302>3.0.co;2-y. [DOI] [PubMed] [Google Scholar]
  5. Fisher B., Carbone P., Economou S. G., Frelick R., Glass A., Lerner H., Redmond C., Zelen M., Band P., Katrych D. L. 1-Phenylalanine mustard (L-PAM) in the management of primary breast cancer. A report of early findings. N Engl J Med. 1975 Jan 16;292(3):117–122. doi: 10.1056/NEJM197501162920301. [DOI] [PubMed] [Google Scholar]
  6. Fisher B., Ravdin R. G., Ausman R. K., Slack N. H., Moore G. E., Noer R. J. Surgical adjuvant chemotherapy in cancer of the breast: results of a decade of cooperative investigation. Ann Surg. 1968 Sep;168(3):337–356. doi: 10.1097/00000658-196809000-00004. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Fisher E. R., Redmond C., Fisher B. Pathologic findings from the National Surgical Adjuvant Breast Project. VIII. Relationship of chemotherapeutic responsiveness to tumor differentiation. Cancer. 1983 Jan 15;51(2):181–191. doi: 10.1002/1097-0142(19830115)51:2<181::aid-cncr2820510202>3.0.co;2-a. [DOI] [PubMed] [Google Scholar]
  8. Holland J. F. Editorial: Major advance in breast-cancer therapy. N Engl J Med. 1976 Feb 19;294(8):440–441. doi: 10.1056/NEJM197602192940809. [DOI] [PubMed] [Google Scholar]
  9. Jones S. E., Salmon S. E., Allen H., Giordano G. F., Davis S., Chase E., Moon T. E., Heusinkveld R. S. Adjuvant treatment of node-positive breast cancer with adriamycin-cyclophosphamide with or without radiation therapy: interim results of an ongoing clinical trial. Recent Results Cancer Res. 1982;80:162–169. doi: 10.1007/978-3-642-81685-7_27. [DOI] [PubMed] [Google Scholar]
  10. Maguire G. P., Tait A., Brooke M., Thomas C., Howat J. M., Sellwood R. A., Bush H. Psychiatric morbidity and physical toxicity associated with adjuvant chemotherapy after mastectomy. Br Med J. 1980 Nov 1;281(6249):1179–1180. doi: 10.1136/bmj.281.6249.1179. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. McArdle C. S., Calman K. C., Cooper A. F., Hughson A. V., Russell A. R., Smith D. C. The social, emotional and financial implications of adjuvant chemotherapy in breast cancer. Br J Surg. 1981 Apr;68(4):261–264. doi: 10.1002/bjs.1800680413. [DOI] [PubMed] [Google Scholar]
  12. Nissen-Meyer R., Kjellgren K., Mansson B. Adjuvant chemotherapy in breast cancer. Recent Results Cancer Res. 1982;80:142–148. doi: 10.1007/978-3-642-81685-7_24. [DOI] [PubMed] [Google Scholar]
  13. Palmer B. V., Walsh G. A., McKinna J. A., Greening W. P. Adjuvant chemotherapy for breast cancer: side effects and quality of life. Br Med J. 1980 Dec 13;281(6255):1594–1597. doi: 10.1136/bmj.281.6255.1594. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Rose D. P., Davis T. E. Effects of adjuvant chemohormonal therapy on the ovarian and adrenal function of breast cancer patients. Cancer Res. 1980 Nov;40(11):4043–4047. [PubMed] [Google Scholar]
  15. Rossi A., Bonadonna G., Valagussa P., Veronesi U. Multimodal treatment in operable breast cancer: five-year results of the CMF programme. Br Med J (Clin Res Ed) 1981 May 2;282(6274):1427–1431. doi: 10.1136/bmj.282.6274.1427. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Rubens R. D., Hayward J. L., Knight R. K., Bulbrook R. D., Fentiman I. S., Chaudary M., Howell A., Bush H., Crowther D., Sellwood R. A. Controlled trial of adjuvant chemotherapy with melphalan for breast cancer. Lancet. 1983 Apr 16;1(8329):839–843. doi: 10.1016/s0140-6736(83)91385-5. [DOI] [PubMed] [Google Scholar]
  17. Samaan N. A., deAsis D. N., Jr, Buzdar A. U., Blumenschein G. R. Pituitary-ovarian function in breast cancer patients on adjuvant chemoimmunotherapy. Cancer. 1978 Jun;41(6):2084–2087. doi: 10.1002/1097-0142(197806)41:6<2084::aid-cncr2820410603>3.0.co;2-y. [DOI] [PubMed] [Google Scholar]
  18. Tormey D. C., Weinberg V. E., Holland J. F., Weiss R. B., Glidewell O. J., Perloff M., Falkson G., Falkson H. C., Henry P. H., Leone L. A. A randomized trial of five and three drug chemotherapy and chemoimmunotherapy in women with operable node positive breast cancer. J Clin Oncol. 1983 Feb;1(2):138–145. doi: 10.1200/JCO.1983.1.2.138. [DOI] [PubMed] [Google Scholar]
  19. Wilcox P. M., Fetting J. H., Nettesheim K. M., Abeloff M. D. Anticipatory vomiting in women receiving cyclophosphamide, methotrexate, and 5-FU (CMF) adjuvant chemotherapy for breast carcinoma. Cancer Treat Rep. 1982 Aug;66(8):1601–1604. [PubMed] [Google Scholar]

Articles from British Medical Journal (Clinical research ed.) are provided here courtesy of BMJ Publishing Group

RESOURCES